Daniel B. Soland

Board Member

Acadia Pharmaceuticals Inc (ACAD)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Acadia Pharmaceuticals Inc (ACAD)
Board Member

SEC 8-K

Current
2024-05-29–present
Acadia Pharmaceuticals Inc (ACAD)
Board Member

Proxy statement

2024-05-29–2025-10-30
DBV Technologies S.A. (DBVT)
Board Member

Proxy statement

Start not stated–2025-09-18
Organization not stated

Board Member

Proxy statement

Start not stated–2022-05-25
DBV Technologies S.A. (DBVT)
Board Member

Proxy statement

Start not stated–2025-10-30
Acadia Pharmaceuticals Inc (ACAD)
Board Member

Proxy statement

Start not stated–2025-10-30

Company network

Recorded roles and call appearances connecting this person to public companies.

Acadia Pharmaceuticals Inc

ACAD

Current role

Board Member

2024-05-29–present

Company

Board Member

DBV Technologies S.A.

DBVT

Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Resigned: Board of Directors DBV Technologies S.A. (DBVT)
2025-10-30
Executive change Resigned: member and Chair of the Nominating and Corporate Governance Committee of the Board Acadia Pharmaceuticals Inc (ACAD)
2025-10-30
Executive change Resigned: member of its Board of Directors DBV Technologies S.A. (DBVT)
2025-09-18
Executive change Appointed: Class II director Acadia Pharmaceuticals Inc (ACAD)
2024-05-29